Literature DB >> 8218681

Antibiotic treatment of Yersinia enterocolitica septicemia: a retrospective review of 43 cases.

M Gayraud1, M R Scavizzi, H H Mollaret, L Guillevin, M J Hornstein.   

Abstract

Of 53 documented cases of Yersinia enterocolitica septicemia reported to the French national registry between 1985 and 1991, 43 files contained sufficient information on antibiotic treatment to be analyzed retrospectively. All patients had at least two positive cultures of blood collected before the initiation of treatment. All strains were susceptible in vitro to the antibiotics that are usually active against gram-negative rods except for older beta-lactam agents (i.e., aminopenicillins and first-generation cephalosporins). No multiresistant strain was isolated. Only four (7.5%) of the 53 patients died. Aminopenicillins, first-generation cephalosporins, and--when prescribed alone--amoxicillin/clavulanate were not effective. Third-generation cephalosporins, most often used in combination with other antibiotics, were successful in 85% of cases. Fluoroquinolones--alone or in combination--cured all of 15 infections, with patients improving rapidly and becoming apyretic within 1-4 days. These agents therefore seem to constitute the best treatment.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8218681     DOI: 10.1093/clinids/17.3.405

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  18 in total

Review 1.  Management of infectious diarrhoea.

Authors:  A C Casburn-Jones; M J G Farthing
Journal:  Gut       Date:  2004-02       Impact factor: 23.059

2.  Axillary abscess due to Yersinia enterocolitica.

Authors:  Barbara E Menzies
Journal:  J Clin Microbiol       Date:  2010-07-14       Impact factor: 5.948

3.  Endocarditis due to Yersinia enterocolitica.

Authors:  E Bonnet; M Archambaud; A Sommabere; C Suc; Z Elias; M Gallinier; P Massabuau; J P Bounhoure; P Massip
Journal:  Infection       Date:  1998 Sep-Oct       Impact factor: 3.553

Review 4.  Optimum treatment of intracellular infection.

Authors:  M Maurin; D Raoult
Journal:  Drugs       Date:  1996-07       Impact factor: 9.546

Review 5.  Yersinia enterocolitica: the charisma continues.

Authors:  E J Bottone
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

Review 6.  Mesenteric lymph node abscess due to Yersinia enterocolitica: case report and review of the literature.

Authors:  Ken Watanabe; Noboru Watanabe; Mario Jin; Tamotsu Matsuhashi; Shigeto Koizumi; Kengo Onochi; Masayuki Sawaguchi; Shin Tawaraya; Hideaki Miyazawa; Hiroshi Uchinami; Yuzo Yamamoto; Hiroshi Nanjo; Hirohide Ohnishi; Hirosato Mashima
Journal:  Clin J Gastroenterol       Date:  2014-01-09

Review 7.  Yersinia enterocolitica endocarditis: case report and literature review.

Authors:  H Giamarellou; A Antoniadou; K Kanavos; C Papaioannou; S Kanatakis; K Papadaki
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-02       Impact factor: 3.267

8.  Assessment of a fluoroquinolone, three beta-lactams, two aminoglycosides, and a cycline in treatment of murine Yersinia pestis infection.

Authors:  S P Bonacorsi; M R Scavizzi; A Guiyoule; J H Amouroux; E Carniel
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

9.  Right Hemicolectomy for Intestinal Obstruction Due to Yersinia pseudotuberculosis: A Histopathological Surprise.

Authors:  K G Srinivasa; J V Vidhya; T M Manohar; M Naik
Journal:  Indian J Surg       Date:  2012-07-04       Impact factor: 0.656

10.  A Case of Septic Arthritis of the Shoulder Due to Yersinia enterocolitica with Review of the Literature.

Authors:  Justin Chan; Rajesh Tim Gandhi
Journal:  Open Forum Infect Dis       Date:  2014-08-02       Impact factor: 3.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.